肝再生的发生机制及血清标志物的研究现状

李嘉妮; 韩川; 王孝平; 汤善宏; 曾维政

doi:10.3969/j.issn.1001-5256.2020.08.048

肝再生的发生机制及血清标志物的研究现状

DOI: 10.3969/j.issn.1001-5256.2020.08.048

1. 西部战区总医院消化内科
2. 西南交通大学

基金项目:

西部战区总医院军事医学研究项目(2019ZY03)；

详细信息

中图分类号: R575
计量
- 文章访问数: 1006
- HTML全文浏览量: 77
- PDF下载量: 262
- 被引次数: 0
出版历程
- 出版日期: 2020-08-20

Current research on liver regeneration:Pathogenesis and serum markers

Department of Gastroenterology, The General Hospital of Western Theater Command

Research funding:

摘要

摘要:
肝再生是在肝损伤及坏死后,为维持肝脏体积及功能,一系列因子和信号转导通路参与的重要反应。其过程包括三个主要阶段:某些因子引发有丝分裂的初始阶段,促进肝细胞重新进入细胞周期的增殖阶段,促使肝细胞达到一定数量及肝脏质量恢复的终止阶段。介绍了促使各种肝干细胞分化为肝细胞以恢复肝脏体积和功能的各种因子及多种细胞信号通路,并归纳了本课题组前期研究发现——AFP是肝衰竭后肝再生的重要血清标志物。经分析表明,深入研究肝再生的发生基础及临床应用,有助于进一步增加对肝再生的了解,更好预测急慢性肝病的预后,为各种晚期肝病的临床诊治提供新的思路和方法。
- 肝再生 /
- 甲胎蛋白类 /
- 生物标记
Abstract:
Liver regeneration is an important response after liver injury and necrosis to maintain liver volume and function,with the involvement of various factors and signaling pathways.This process has three main stages,i.e.,the initial stage of mitosis triggered by certain factors,the proliferation stage of promoting hepatocytes to enter the cell cycle,and the termination stage of promoting liver cells to reach a certain number and the recovery of liver mass.This article introduces various factors and multiple cellular signaling pathways that promote the differentiation of liver stem cells into liver cells to restore liver volume and function and summarizes the previous research findings of our group that alpha-fetoprotein is an important serum marker for liver regeneration after liver failure.The analysis shows that in-depth studies of the occurrence and clinical application of liver regeneration will help to improve the understanding of liver regeneration,better predict the prognosis of acute and chronic liver diseases,and provide new ideas and methods for the clinical diagnosis and treatment of various advanced liver diseases.
- liver regeneration /
- alpha-fetoproteins /
- biomarkers

HTML全文

参考文献(38)

[1] FAUSTO N,CAMPBELL JS. The role of hepatocytes and oval cells in liver regeneration and repopulation[J]. Mech Dev,2003,120(1):117-130.

[2] YANG XG,ZHU L,HE CC,et al. Research advance of hepatic stem cells and liver damage repair[J]. Bull Sci Technol,2017,33(6):90-95.(in Chinese)杨献光，朱琳，和春翠，等．肝干细胞和肝损伤修复的研究进展[J]．科技通报，2017,33(6):90-95.

[3] TIRNITZ-PARKER JE,VIEBAHN CS,JAKUBOWSKI A,et al.Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells[J]. Hepatology,2010,52(1):291-302.

[4] SATYANARAYANA A,WIEMANN SU,BUER J,et al. Telomere shortening impairs organ regeneration by inhibiting cell cycle reentry of a subpopulation of cells[J]. EMBO J,2003,22(15):4003-4013.

[5] MALATO Y,NAQVI S,SCHRMANN N,et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration[J]. J Clin Invest,2011,121(12):4850-4860.

[6] FENG RX,DENG X,ZHANG X,et al. Advances study in liver regeneration[J]. Chin J Gastroenterol,2015,20(3):169-173.(in Chinese)冯仁鑫，邓星，张新，等．肝再生研究进展[J]．胃肠病学，2015,20(3):169-173.

[7] KAKISAKA K,KATAOKA K,ONODERA M,et al. Alpha-fetoprotein:A biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure[J]. Hepatol Res,2015,45(10):e12-e20.

[8] DENG X,ZHANG X,LI W,et al. Chronic liver injury induces conversion of biliary epithelial cells into hepatocytes[J]. Cell Stem Cell,2018,23(1):114-122. e3.

[9] MAGNER NL,JUNG Y,WU J,et al. Insulin and IGFs enhance hepatocyte differentiation from human embryonic stem cells via the PI3K/AKT pathway[J]. Stem Cells,2013,31(10):2095-2103.

[10] WANG L,WANG X,XIE G,et al. Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in rats[J]. J Clin Invest,2012,122(4):1567-1573.

[11] TSOLAKI E,ATHANASIOU E,GOUNARI E,et al. Hematopoietic stem cells and liver regeneration:Differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury[J]. Blood Cells Mol Dis,2014,53(3):124-132.

[12] YANG L,WANG Y,WANG X,et al. Effect of allogeneic umbilical cord mesenchymal stem cell transplantation in a rat model of hepatic cirrhosis[J]. J Tradit Chin Med,2015,35(1):63-68.

[13] ELCHANINOV A,FATKHUDINOV T,USMAN N,et al. Multipotent stromal cells stimulate liver regeneration by influencing the macrophage polarization in rat[J]. World J Hepatol,2018,10(2):287-296.

[14] MICHAEL K,HANS C. Reparative inflflammation takes charge of tissue regeneration[J]. Nature,2016,529(7586):307-315.

[15] SIDRAH N,TABINDA H,SOBIA M,et al. Interleukin-6:A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies[J]. Cytokine Ggrowth Factor Rev,2018,39:36-45.

[16] TAUB R. Liver regeneration:From myth to mechanism[J].Nat Rev Mol Cell Biol,2004,5(10):836-847.

[17] KIM AR,PARK JI,OH HT,et al. TAZ stimulates liver regeneration through interleukin-6-induced hepatocyte proliferation and inhibition of cell death after liver injury[J]. FASEB J,2019,33(5):5914-5923.

[18] TANIGUCHI K,WU LW,GRIVENNIKOV SI,et al. A gp130-Src-YAP module links inflammation to epithelial regeneration[J]. Nature,2015,519(7541):57-62.

[19] YANG X,HE C,ZHU L,et al. Comparative analysis of regulatory role of notch signaling pathway in 8 types liver cell during liver regeneration[J]. Biochem Genet,2019,57(1):1-19.

[20] LI W,YANG L,HE Q,et al. A homeostatic arid1a-dependent permissive chromatin state licenses hepatocyte responsiveness to liver-injury-associated YAP signaling[J]. Cell Stem Cell,2019,25(1):54-68,e5.

[21] XU L,GU L,TAO X,et al. Effect of dioscin on promoting liver regeneration via activating Notch1/Jagged1 signal pathway[J]. Phytomedicine,2018,38:107-117.

[22] MICHALOPOULOS GK. Liver regeneration after partial hepatectomy:Critical analysis of mechanistic dilemmas[J]. Am J Pathol,2010,176(1):2-13.

[23] MAO SA,GLORIOSO JM,NYBERG SL. Liver regeneration[J]. Transl Res,2014,163(4):352-362.

[24] MOHAMMED FF,PENNINGTON CJ,KASSIRI Z,et al. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration[J]. Hepatology,2005,41(4):857-867.

[25] SHIMIZU M,HARA A,OKUNO M,et al. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice:Impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis[J]. Hepatology,2001,33(3):569-576.

[26] CHATURANTABUT S,SHWARTZ A,EVASON KJ,et al. Estrogen activation of G-protein-coupled estrogen receptor 1regulates phosphoinositide 3-kinase and m TOR signaling to promote liver growth in zebrafish and proliferation of human hepatocytes[J]. Gastroenterology,2019,156(6):1788-1804,e13.

[27] MONGA SP. Role of Wnt/β-catenin signaling in liver metabolism and cancer[J]. Int J Biochem Cell Biol,2011,43(7):1021-1029.

[28] ROMERO-GALLO J,SOZMEN EG,CHYTIL A,et al. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy[J].Oncogene,2005,24(18):3028-3041.

[29] GUI Y,YEGANEH M,RAMANATHAN S,et al. SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes[J]. J Hepatol,2011,55(6):1300-1308.

[30] CAMPBELL JS,PRICHARD L,SCHAPER F,et al. Expression of suppressors of cytokine signaling during liver regeneration[J]. J Clin Invest,2001,107(10):1285-1292.

[31] SCHAPER F,ROSE-JOHN S. Interleukin-6:Biology,signaling and strategies of blockade[J]. Cytokine Growth Factor Rev,2015,26(5):475-487.

[32] TAKIKAWA Y,SUZUKI K. Is AFP a new reliable marker of liver regeneration in acute hepatic failure?[J]. J Gastroenterol,2002,37(8):681-682.

[33] FRANK VS,GEORGE O,NATALIE M,et al. Alpha-fetoprotein and prognosis in acute liver failure[J]. Liver Transpl,2006,12(12):1776-1781.

[34] SCHMIDT LE,DALHOFF K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury[J]. Hepatology,2005,41(1):26-31.

[35] YANG SS,CHENG KS,LAI YC,et al. Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B[J]. J Gastroenterol,2002,37(8):626-632.

[36] LISE LK,JIANPING L,BODIL A,et al. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure:A systematic review[J]. JAMA,2003,289(2):217-222.

[37] WANG X,SHEN C,YANG J,et al. Alpha-fetoprotein as a predictive marker for patients with hepatitis B-related acuteon-chronic liver failure[J]. Can J Gastroenterol Hepatol,2018,2018:1232785.

[38] QIN S,TANG SH,WANG XH,et al. The value of serum AFP in HBV-ACLF patients treated with artificial liver[J]. Chin J Hepatol,2020,28(1):76-80.(in Chinese)秦森，汤善宏，王显红，等．血清甲胎蛋白在人工肝治疗乙型肝炎相关慢加急性肝衰竭预后评估中的价值[J]．中华肝脏病杂志，2020,28(1):76-80.

施引文献

资源附件(0)

访问统计